Protein LC-MS Tools for the Next Generation of Biotherapeutic Analyses from Preclinical and Clinical Serum
Journal of the American Society for Mass Spectrometry · 2023
DOI: 10.1021/jasms.3c00064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, 2023. Verfasst von Nicole A Schneck und 2 weiteren Autor:innen. Beteiligte Einrichtung: Analytical Development, GSK, 1250 S. Collegeville Rd., Collegeville, Pennsylvania 19426, United States. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Analytical Development, GSK, 1250 S. Collegeville Rd., Collegeville, Pennsylvania 19426, United States.
- Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd., Collegeville, Pennsylvania 19426, United States.
ORCID-Profile: John F Kellie
Zitieren
APA
Schneck, N. A., Mehl, J. T., & Kellie, J. F. (2023). Protein LC-MS Tools for the Next Generation of Biotherapeutic Analyses from Preclinical and Clinical Serum. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.3c00064
Vancouver
Schneck NA, Mehl JT, Kellie JF. Protein LC-MS Tools for the Next Generation of Biotherapeutic Analyses from Preclinical and Clinical Serum. Journal of the American Society for Mass Spectrometry. 2023. doi:10.1021/jasms.3c00064
BibTeX
@article{Schneck2023,
author = {Schneck, Nicole A and Mehl, John T and Kellie, John F},
title = {Protein LC-MS Tools for the Next Generation of Biotherapeutic Analyses from Preclinical and Clinical Serum},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2023},
doi = {10.1021/jasms.3c00064}
}
EUVIMED